期刊文献+

人乳头瘤病毒16型晚期基因L1在大肠杆菌中的表达 被引量:1

ESTABLISHMENT AND IDENTIFICATION OF EXPRESSION SYSTEM OF LATE GENE L1 OF HUMAN PAPILLOMAVIRUS TYPE 16 IN E.coli
下载PDF
导出
摘要 人乳头瘤病毒(HPV)感染与宫颈癌的发生关系密切。其晚期蛋白L1是主要结构蛋白,可以刺激机体产生中和抗体,对病毒攻击可以起到保护作用。本研究将HPV16型中国分离株的L1基因定向克隆到原核表达载体pET-21c质粒中,建立HPV16 L1在大肠杆菌中的高效表达系统pET21c-HPV16L1,该系统在IPTG的诱导下可表达 60ku的 L1蛋白,表达效率为 23%,此蛋白通过Western-blot得到证实。该表达体系的成功建立可以为进一步研究HPV16 L1蛋白的分子和免疫学特性以及基因疫苗的研制提供实验依据。 Human papillomavirus type 16 (HPV16) is thought to be a very important etiological factor of cervical carcino- ma. The late protein L1 of HPV16 is the main structUral protein, which induce antibody that can neutralize the infection of HPV16. The L1 gene of HPV16 Chinese strain was clamal into plasmid pET-21c. An inducible expression system for HPV16L1 gene in E. coli, pET-21c-HPV16L1 was constructed. Polyacryldride gel electrophoresis showed that pET-21c- HPV16L1 could express L1 protein in size of about 60 KD in E. coli BL21-DE3 under induction of IPTG. The expression effi- ciency was 23 %. The protein was confirmal by western-blot.
出处 《微生物学杂志》 CAS CSCD 2000年第4期22-23,54,共3页 Journal of Microbiology
基金 黑龙江省科委重点攻关项目资助(G98-C0803)
关键词 人类乳头瘤病毒16型 晚期基因L1 基因表达 大肠杆菌 HPV16 late gene gene expression E.colt
  • 相关文献

参考文献2

二级参考文献1

  • 1(美)J.萨姆布鲁克(J.Sambrook)等著,金冬雁等.分子克隆实验指南[M]科学出版社,1992.

共引文献4

同被引文献12

  • 1马正海,张富春,梅新娣,马彩玲,刘开江.新疆南部地区维吾尔族妇女宫颈癌组织中人乳头状瘤病毒16型L1基因突变谱分析[J].中华医学杂志,2004,84(12):987-991. 被引量:18
  • 2李昂,杨谨,来宝长,耿宜萍,王艳,王一理,司履生.人乳头瘤病毒18型L1-E6、E7嵌合基因DNA疫苗的体内免疫效应[J].细胞与分子免疫学杂志,2004,20(6):760-763. 被引量:4
  • 3李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 4Hwang TS,Jeong JK,Park M,et al.Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray[J].Gynecol Oncol,2003,90:51-56.
  • 5Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Bri J Cancer, 2003, 88: 63- 73.
  • 6Schiller JT, Lowy DR. Papillomavirus-like particle vaccines [J]. J Natl Cancer Inst Monogr, 2001, 28:50 - 54.
  • 7Nardelli-Haefliger D, Roden RB, Benyacoub J, et al. Human papillo-mavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice[J]. Infect Immun, 1997, 65:3328 - 3336.
  • 8Ohlschlager P, Osen W, Dell K, et al. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice[J]. J Virol, 2003, 77:4635-4645.
  • 9Zhang W, Carmichael J, Ferguson J, et al. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation,renaturation, and self-assembly of virus-like particles in vitro [J]. Virology, 1998, 243(2):423 - 431.
  • 10Yuan H, Estes PA, Chen Y, et al. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection [J]. J Virol, 2001,75(17): 7848-7853.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部